Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
The number of people who need obesity drugs coupled with their price has made it difficult for health insurance plans to cover them
Caution is advised in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Albiglutide was found to be ineffective in improving weight outcomes versus traditional drugs
9 The STEP 8 trial directly compared once-weekly semaglutide, 2.4 mg, vs once-daily liraglutide, 3.0 mg, for weight management in adults with overweight or obesity to rigorously assess differences in efficacy and adverse event (AE) profiles
US$ 23.25
US$ 20.50
US$ 21.46
